Company / CapEx per Share
Incyte CapEx per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.22
FY2024
5-year range
$0.22 / $0.82
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#43 of 192
Health Care
What the data says
Incyte's capex per share of $0.22 is higher than 78% of companies in the Health Care sector (FY2024). CapEx per Share has fluctuated over the past 8 years, ranging from $0.22 in FY2024 to $0.82 in FY2021.
Based on SEC 10-K filings.
0.22 in FY2024 with a 5-year CAGR of -16.0%. Top quartile in the Health Care sector.
Declined from $0.82 to $0.22 over the past 3 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -35.9%
- 5-Year CAGR
- -16.0%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 192This company $0.22 Sector average $3.54
▼
-93.9% below sector average
Key checks
Key Insights
- Ranks #43 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.22 | - |
| FY2023 | - | - |
| FY2022 | $0.35 | -57.3% |
| FY2021 | $0.82 | +142.6% |
| FY2020 | $0.34 | -34.7% |
| FY2019 | $0.52 | +49.7% |
| FY2018 | $0.35 | -40.8% |
| FY2017 | $0.59 | -8.8% |
| FY2016 | $0.64 | +323.5% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026